Results 71 to 80 of about 2,887 (179)

Antagonizing the angiotensin II subtype 1 receptor: a focus on olmesartan medoxomil

, 2004
BACKGROUND: The orally active, nonpeptide antagonists of the angiotensin II subtype 1 (AT1) receptor represent a recent class of antihypertensive drugs that selectively block the renin-angiotensin system. Olmesartan medoxomil is the newest member of this
Nussberger, J., Koike, H.
core   +1 more source

Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors

Кардиоваскулярная терапия и профилактика, 2010
Aim. May blockade of the angiotensin II type 1 receptor (AT1) with an angiotensin receptor blocker reverse vascular pathology independent of blood pressure (BP) lowering. Material and methods.
R. D. Smith, H. Yokoyamaa, D. B. Averill, E. L. Schiffrin, C. M. Ferrario   +4 more
doaj  

Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system

Кардиоваскулярная терапия и профилактика, 2011
The extent to which the clinical effects of angiotensin receptor blockers (ARB) are related to ambient renin system activity remains poorly defined.
L. M. Resnick, D. Catanzaro, J. E. Sealey, J. H. Laragh   +3 more
doaj   +1 more source

Chronopharmacology of Angiotensin II–receptor Blockers in Stroke-Prone Spontaneously Hypertensive Rats

Journal of Pharmacological Sciences, 2011
Protective effect of valsartan (Val), an angiotensin II (AII)-receptor blocker (ARB), against organ damage is reported to depend on the dosing time in hypertensive patients.
Yuwang Liu, Kentarou Ushijima, Masami Ohmori, Makoto Takada, Masato Tateishi, Hitoshi Ando, Akio Fujimura   +6 more
doaj   +1 more source

Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study

Vascular Health and Risk Management, 2009
Vivencio Barrios1, Carlos Escobar1, Alberto Calderon2, Michael Böhm31Department of Cardiology, Hospital Ramón y Cajal, Madrid, Spain; 2Primary Care Center Rosa de Luxemburgo, Madrid, Spain; 3Klinik für Innere Medizin III ...
Vivencio Barrios, Carlos Escobar, Alberto Calderon, et al   +3 more
doaj  

Long-Term Efficacy of Olmesartan Medoxomil in Chinese Hypertensive Patients as Assessed by Clinic, Ambulatory and Home Blood Pressure Measurements [PDF]

, 2012
Background and Objectives There is limited information on the long-term efficacy and safety of olmesartan medoxomil in the management of hypertension in Chinese patients.
Ning-Ling Sun, Naotaka Ikegami, Ji-Guang Wang, Jun-Ren Zhu, Zhang, Bo-Heng, Zhu, Jun-Ren, Ke, Yuan-Nan, Wang, Ji-Guang, Yuan-Nan Ke, Bo-Heng Zhang, Ikegami, Naotaka, Sun, Ning-Ling   +11 more
core   +1 more source

Method Validation for Simultaneous Quantification of Olmesartan and Hydrochlorothiazide in Human Plasma Using LC-MS/MS and Its Application Through Bioequivalence Study in Healthy Volunteers

Frontiers in Pharmacology, 2019
A new, simple, sensitive, selective, rapid, and high-throughput liquid chromatography-tandem mass spectrometry (LC-MS/MS) method has been developed and validated for simultaneous quantification of Olmesartan and hydrochlorothiazide in human plasma ...
Arvind Kumar, Arvind Kumar, Surya Prakash Dwivedi, Tulika Prasad   +3 more
doaj   +1 more source

Development and Validation of Dual Wavelength UV Spectrophotometric Method for simultaneous estimation of Cilnidipine and Olmesartan Medoxomil in Tablet dosage form [PDF]

, 2014
A simple and economical dual wavelength spectrophotometric method has been developed for the simultaneous estimation of Cilnidipine and Olmesartan Medoxomil in their tablet dosage form.
Isha J. Soni, Hiral J. Panchal, Panchal, Hiral J., Soni, Isha J.   +3 more
core   +1 more source

Development and validation of reversed phase gradient HPLC method for the simultaneous estimation of olmesartan medoxomil and chlorthalidone in dosage forms

, 2020
The main objective of the proposed study is to develop and validate a new stability indicating reverse phase HPLC gradient method for the simultaneous estimation of olmesartan medoxomil and chlorthalidone in combined dosage form.
S Manikandan, G Thirunarayanan
core   +1 more source

Development of Buccal Adhesive Tablets of Olmesartan Medoxomil. [PDF]

, 2014
The most preferred route of drug administration for systemic delivery of drugs is oral route. More than 50% of drug delivery systems available in the market are oral drug delivery systems.
Rajeshkumar, J
core